Fexofenadine/Phenylephrine

非索非那定/去氧肾上腺素

Report date: 2022/09/06 17:03:40

Base Information

Drug NameFexofenadine/Phenylephrine
Drug Alias Name去氧肾上腺素+非索非那定Phenylephrine/fexofenadinePE10+FEX60去氧肾上腺素/非索非那定FEX60/PE10 +[10] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAdrenergic receptor alpha-1 agonists
TargetsHistamine H1 receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Phenylephrine HydrochlorideFexofenadine Hydrochloride
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A